Vedant Borad
Plastic and Reconstructive Surgery · Newburgh, INNPI 1114314374
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,219 of the $1,519 with a category attached, or 80.2%. 12 manufacturers reported payments, led by AbbVie at 51.7% of the total. Reporting peaked in 2022 at $513 and has fallen 64.3% since, to $183 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in IN, where the typical reported total is $2,233.
Across 71 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$786
- Medical Device Business Services, Inc.$300
- Sientra, Inc.$151
- Kls-martin L.p.$99
- Kerecis Limited$41
- Mentor Worldwide LLC$37
- plus $104 from 6 others
What the payments were for
- Food & beverage$1,21980%
- Education$30020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $786 |
| Medical Device Business Services, Inc. | 1 | $300 |
| Sientra, Inc. | 8 | $151 |
| Kls-martin L.p. | 2 | $99 |
| Kerecis Limited | 2 | $41 |
| Mentor Worldwide LLC | 2 | $37 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Solventum Corporation | 1 | $22 |
| TELA Bio, Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $15 |
| Polynovo North America LLC | 1 | $13 |
| Aroa Biosurgery Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,519 in reported general payments places this provider in the 40th percentile of 47 plastic and reconstructive surgery providers in Indiana.
See all plastic and reconstructive surgery providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 37 | $345 |
| Oxycodone Hcl | 46 | $73 |
| Ondansetron OdtOndansetron | 21 | $59 |
| Hydroxyzine Hcl | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Newburgh
- James ConkrightNewburgh$8K
- Ayaz ShaikhNewburgh$15
- Aaron MullNewburgh$0
- Aladdin HassaneinIndianapolis$103K
- Leigh SperaIndianapolis$16K
- Janet TurkleCarmel$15K
- Dion ChavisIndianapolis$15K
- David RobinsonMunster$9K
- Christopher JonesIndianapolis$7K
- Erin WeberIndianapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.